TRPC1 and ovarian hyperstimulation syndrome: Our study's strengths are that it is the first to examine the activities of TRPC1 and cytokines in OHSS, the first to examine the effects of cabergoline and nifedipine on these parameters, and the first to examine the pathophysiology of OHSS from a different angle.